|
|
|
Insider
Information: |
Kakkis Emil D |
Relationship: |
|
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
604,218 |
|
Indirect Shares
|
2,228,639 |
|
|
Direct
Value |
$36,088,856 |
|
|
Indirect Value
|
$128,736,419 |
|
|
Total
Shares |
2,832,857 |
|
|
Total
Value |
$164,825,275 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-09-03 |
564,597 |
2024-09-03 |
2,223,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
|
2004-10-31 |
4 |
A |
$3.51 |
$6,754 |
D/D |
1,924 |
25,034 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
|
2005-05-02 |
4 |
A |
$3.43 |
$6,758 |
D/D |
1,968 |
27,002 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-10-31 |
4 |
A |
$3.43 |
$8,832 |
D/D |
2,572 |
29,574 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2006-04-28 |
4 |
A |
$3.43 |
$14,430 |
D/D |
4,202 |
33,776 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
163,304 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
624,240 |
624,240 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
635,640 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,700 |
527,147 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
432,647 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
450,069 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,429 |
452,384 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
470,472 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2019-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
20,000 |
470,473 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,435 |
470,220 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,435 |
475,914 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,782 |
511,696 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,453 |
612,394 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
52,041 |
634,226 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
54,916 |
615,606 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
41,560 |
563,913 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2008-04-30 |
4 |
AB |
$10.37 |
$17,007 |
D/D |
1,640 |
162,804 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2008-10-31 |
4 |
AB |
$13.35 |
$4,233 |
D/D |
317 |
115,621 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
|
2003-12-29 |
4 |
AS |
$7.57 |
$77,120 |
I/I |
(10,187) |
11,110 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2008-03-06 |
4 |
AS |
$37.99 |
$686,870 |
D/D |
(18,000) |
86,164 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2008-04-01 |
4 |
AS |
$35.71 |
$353,835 |
D/D |
(9,857) |
86,164 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|